Global X Genomics & Biotechnology ETF (GNOM) Covered Calls

Global X Genomics & Biotechnology ETF covered calls Complete Genomics Inc is a life sciences company that has developed and commercialized an innovative DNA sequencing platform that provides preferred solution for complete human genome sequencing and analysis.

You can sell covered calls on Global X Genomics & Biotechnology ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GNOM (prices last updated Mon 4:16 PM ET):

Global X Genomics & Biotechnology ETF (GNOM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.47 +0.05 10.10 11.35 50K - 0.1
Covered Calls For Global X Genomics & Biotechnology ETF (GNOM)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 10 0.00 11.35 -11.9% -362.0%
Jun 21 10 0.00 11.35 -11.9% -92.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Complete Genomics, Inc. is a life sciences company, which develops and commercializes an innovative DNA sequencing platform for complete human genome sequencing and analysis. The company provides Complete Genomics Analysis Platform, which combines its proprietary human genome sequencing technology with the company's advanced informatics and data management software. The company offers innovative, end-to-end, outsourced service model to the customers with data that is immediately ready to be used for genome-based research. Its technology allow academic and biopharmaceutical researchers to conduct large-scale complete human genome studies that will help in identifying the genetic underpinnings of complex diseases and drug responses. Complete Genomics was founded by Clifford A. Reid, Radoje Drmanac and Robert John Curson on June 14, 2005 and is headquartered in Mountain View, CA.